Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keita Nagai

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Micromachines|February 24, 2024
Batch Fine Magnetic Pattern Transfer Method on Permanent Magnets Using Coercivity Change during Heating for Magnetic MEMSKeita Nagai, Naohiro Sugita, Tadahiko Shinshi
Aesthetic Surgery Journal|July 1, 2023
Detailed Analysis of Three Major Breast Reconstructions Using BREAST-Q Responses From 1001 PatientsShoichi Tomita, Keita Nagai, Noriko Matsunaga, et al.
Development, Growth & Differentiation|May 28, 2009
The Sperm-surface glycoprotein, SGP, is necessary for fertilization in the frog, Xenopus laevisKeita Nagai, Takuya Ishida, Takafumi Hashimoto, et al.
FEBS Letters|November 20, 2017
Mitochondrial intermediate peptidase is a novel regulator of sirtuin-3 activation by caloric restrictionMasaki Kobayashi, Kanae Takeda, Takumi Narita, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonistsNagaaki Sato, Makoto Jitsuoka, Shiho Ishikawa, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2009
Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonistsTakao Suzuki, Minoru Moriya, Toshihiro Sakamoto, et al.
Journal of Medicinal Chemistry|May 23, 2009
Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effectNagaaki Sato, Makoto Ando, Shiho Ishikawa, et al.
Bioorganic & Medicinal Chemistry|July 21, 2009
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptorMakoto Ando, Nagaaki Sato, Tsuyoshi Nagase, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Micromachines|February 24, 2024
Batch Fine Magnetic Pattern Transfer Method on Permanent Magnets Using Coercivity Change during Heating for Magnetic MEMSKeita Nagai, Naohiro Sugita, Tadahiko Shinshi
Aesthetic Surgery Journal|July 1, 2023
Detailed Analysis of Three Major Breast Reconstructions Using BREAST-Q Responses From 1001 PatientsShoichi Tomita, Keita Nagai, Noriko Matsunaga, et al.
Development, Growth & Differentiation|May 28, 2009
The Sperm-surface glycoprotein, SGP, is necessary for fertilization in the frog, Xenopus laevisKeita Nagai, Takuya Ishida, Takafumi Hashimoto, et al.
FEBS Letters|November 20, 2017
Mitochondrial intermediate peptidase is a novel regulator of sirtuin-3 activation by caloric restrictionMasaki Kobayashi, Kanae Takeda, Takumi Narita, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonistsNagaaki Sato, Makoto Jitsuoka, Shiho Ishikawa, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2009
Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonistsTakao Suzuki, Minoru Moriya, Toshihiro Sakamoto, et al.
Journal of Medicinal Chemistry|May 23, 2009
Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effectNagaaki Sato, Makoto Ando, Shiho Ishikawa, et al.
Bioorganic & Medicinal Chemistry|July 21, 2009
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptorMakoto Ando, Nagaaki Sato, Tsuyoshi Nagase, et al.
Pageof 1